Contact Us
×Thank you for taking the time to help us improve the Console.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Responsive COVID-19 Vaccines for Recovery Project under the Asia Pacific Vaccine Access Facility
Sectors
Issues Raised
Project Information
Investment ID: 4083-SRI
Bank: Asian Development Bank
Environmental Category: B
Country: Sri Lanka
Region: South Asia
Approval Date: July 8, 2021
Investment Types: Loans
Total Project Cost: USD 95.9 million
Total Complaints: 2
Description
The project will provide the Government of Sri Lanka with immediate and flexible financing to support the national COVID-19 vaccination program through APVAX and the regular country allocation. The APVAX allocation comprises a rapid response component (RRC) to support the purchase of Asian Development Bank (ADB) eligible COVID-19 vaccines, while the project investment component (PIC) financed by the regular country allocation will support strengthening of the vaccination information dissemination and monitoring systems, vaccine transportation capacity, and vaccine-related medical waste management.
Investments
Related Complaints